These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10096969)
1. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. D'Amico TA; Massey M; Herndon JE; Moore MB; Harpole DH J Thorac Cardiovasc Surg; 1999 Apr; 117(4):736-43. PubMed ID: 10096969 [TBL] [Abstract][Full Text] [Related]
2. Molecular biologic substaging of stage I lung cancer according to gender and histology. D'Amico TA; Aloia TA; Moore MB; Herndon JE; Brooks KR; Lau CL; Harpole DH Ann Thorac Surg; 2000 Mar; 69(3):882-6. PubMed ID: 10750777 [TBL] [Abstract][Full Text] [Related]
3. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery. Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. Pastorino U; Andreola S; Tagliabue E; Pezzella F; Incarbone M; Sozzi G; Buyse M; Menard S; Pierotti M; Rilke F J Clin Oncol; 1997 Aug; 15(8):2858-65. PubMed ID: 9256129 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer. Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368 [TBL] [Abstract][Full Text] [Related]
11. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. Yoo J; Jung JH; Lee MA; Seo KJ; Shim BY; Kim SH; Cho DG; Ahn MI; Kim CH; Cho KD; Kang SJ; Kim HK J Korean Med Sci; 2007 Apr; 22(2):318-25. PubMed ID: 17449943 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer. Noma D; Inamura K; Matsuura Y; Hirata Y; Nakajima T; Yamazaki H; Hirai Y; Ichinose J; Nakao M; Ninomiya H; Mun M; Nakagawa K; Masuda M; Ishikawa Y; Okumura S Clin Lung Cancer; 2018 Jan; 19(1):e109-e122. PubMed ID: 29066222 [TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer. Dziedzic DA; Rudzinski P; Langfort R; Orlowski T; Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. Duarte IG; Bufkin BL; Pennington MF; Gal AA; Cohen C; Kosinski AS; Mansour KA; Miller JI J Thorac Cardiovasc Surg; 1998 Mar; 115(3):652-8; discussion 658-9. PubMed ID: 9535454 [TBL] [Abstract][Full Text] [Related]
16. Cell proliferation and apoptosis in stage III inoperable non-small cell lung carcinoma treated by radiotherapy. Langendijk H; Thunnissen E; Arends JW; de Jong J; ten Velde G; Lamers R; Guinee D; Holden J; Wouters M Radiother Oncol; 2000 Aug; 56(2):197-207. PubMed ID: 10927139 [TBL] [Abstract][Full Text] [Related]
17. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer. Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection. Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287 [TBL] [Abstract][Full Text] [Related]
19. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer. Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer. Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]